These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 18060472

  • 1. Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.
    Capo CR, Arciello M, Squitti R, Cassetta E, Rossini PM, Calabrese L, Rossi L.
    Biometals; 2008 Jun; 21(3):367-72. PubMed ID: 18060472
    [Abstract] [Full Text] [Related]

  • 2. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
    Squitti R, Pasqualetti P, Dal Forno G, Moffa F, Cassetta E, Lupoi D, Vernieri F, Rossi L, Baldassini M, Rossini PM.
    Neurology; 2005 Mar 22; 64(6):1040-6. PubMed ID: 15781823
    [Abstract] [Full Text] [Related]

  • 3. Ceruloplasmin in neurodegenerative diseases.
    Vassiliev V, Harris ZL, Zatta P.
    Brain Res Brain Res Rev; 2005 Nov 22; 49(3):633-40. PubMed ID: 16269323
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.
    Boström F, Hansson O, Gerhardsson L, Lundh T, Minthon L, Stomrud E, Zetterberg H, Londos E.
    Neurobiol Aging; 2009 Aug 22; 30(8):1265-71. PubMed ID: 18191875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
    Park JH, Lee DW, Park KS.
    Asia Pac Psychiatry; 2014 Mar 22; 6(1):38-45. PubMed ID: 23857910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease.
    Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, Ames D, Masters CL, AIBL research group, Bush AI.
    J Alzheimers Dis; 2013 Mar 22; 34(1):171-82. PubMed ID: 23168449
    [Abstract] [Full Text] [Related]

  • 12. Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.
    De Riccardis L, Buccolieri A, Muci M, Pitotti E, De Robertis F, Trianni G, Manno D, Maffia M.
    Biochim Biophys Acta Mol Basis Dis; 2018 May 22; 1864(5 Pt A):1828-1838. PubMed ID: 29524632
    [Abstract] [Full Text] [Related]

  • 13. Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.
    Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, Finkelman JH, Pomara N, LeWitt PA.
    Alzheimer Dis Assoc Disord; 1994 May 22; 8(3):190-7. PubMed ID: 7986488
    [Abstract] [Full Text] [Related]

  • 14. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ, Blennow K.
    Arch Neurol; 2008 Aug 22; 65(8):1102-7. PubMed ID: 18695061
    [Abstract] [Full Text] [Related]

  • 15. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN, Lee HW, Cho JY, Suk K.
    Brain Res; 2009 Apr 10; 1265():158-70. PubMed ID: 19368810
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ceruloplasmin in neurodegenerative diseases.
    Texel SJ, Xu X, Harris ZL.
    Biochem Soc Trans; 2008 Dec 10; 36(Pt 6):1277-81. PubMed ID: 19021540
    [Abstract] [Full Text] [Related]

  • 18. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L, Squitti R, Calabrese L, Rotilio G, Rossini PM.
    J Nutr Health Aging; 2007 Dec 10; 11(5):408-17. PubMed ID: 17657362
    [Abstract] [Full Text] [Related]

  • 19. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
    Gerhardsson L, Lundh T, Minthon L, Londos E.
    Dement Geriatr Cogn Disord; 2008 Dec 10; 25(6):508-15. PubMed ID: 18463412
    [Abstract] [Full Text] [Related]

  • 20. Ceruloplasmin, an indicator of copper status.
    Arredondo M, González M, Olivares M, Pizarro F, Araya M.
    Biol Trace Elem Res; 2008 Dec 10; 123(1-3):261-9. PubMed ID: 18270661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.